Suppr超能文献

一种非苯二氮䓬类部分激动剂S-(+)-DN-2327产生身体依赖性的可能性极小,但在大鼠中对巴比妥类药物表现出交叉依赖性。

A nonbenzodiazepine partial agonist, S-(+)-DN-2327, has minimal physical dependence-producing liability, but shows cross-dependence on barbital in rats.

作者信息

Inui Y, Yamamoto M, Awasaki Y, Nishida N

机构信息

Drug Safety Research Laboratories, Takeda Chemical Industries Ltd., Osaka, Japan.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1996 Oct;20(7):1197-211. doi: 10.1016/s0278-5846(96)00106-6.

Abstract
  1. Physical dependence and cross-physical dependence on barbital of the benzodiazepine receptor partial agonist S-(+)-DN-2327 and the benzodiazepine receptor full agonist diazepam were compared in male Fischer 344 rats. 2. In the physical dependence study, rats were treated with S-(+)-DN-2327 (30, 100, 300 and 1000 mg/kg/day) or diazepam (30, 100 and 300 mg/kg/day) for 4 weeks by the drug admixed with food method. After stopping the treatment, the body weight and food consumption in the diazepam 100 and 300 mg/kg groups tended to decrease or decreased to values lower than those in the control group, whereas these parameters in the S-(+)-DN-2327 30, 100 and 300 mg/kg groups were comparable to the control group values. 3. In the cross-dependence study, rats were treated with increasing doses of barbital by admixing the drug with food for 4 weeks, after which the diet admixed with barbital was replaced by basal diet alone or admixed with S-(+)-DN-2327 or diazepam (target doses: 100 and 300 mg/kg/day for each compound). During the substitution period, the decreases in body weight and food consumption in both S-(+)-DN-2327 and both diazepam groups were suppressed compared with those in the basal diet group. 4. These results suggest that S-(+)-DN-2327 possesses minimal physical dependence-producing liability, but shows cross-dependence on barbital, as do benzodiazepine receptor full agonists.
摘要
  1. 在雄性Fischer 344大鼠中比较了苯二氮䓬受体部分激动剂S-(+)-DN-2327和苯二氮䓬受体完全激动剂地西泮对巴比妥的身体依赖性和交叉身体依赖性。2. 在身体依赖性研究中,通过药物与食物混合的方法,用S-(+)-DN-2327(30、100、300和1000毫克/千克/天)或地西泮(30、100和300毫克/千克/天)对大鼠进行4周治疗。停止治疗后,地西泮100和300毫克/千克组的体重和食物消耗量趋于下降或降至低于对照组的值,而S-(+)-DN-2327 30、100和300毫克/千克组的这些参数与对照组值相当。3. 在交叉依赖性研究中,通过将药物与食物混合4周,用递增剂量的巴比妥对大鼠进行治疗,之后将与巴比妥混合的饮食替换为仅基础饮食或与S-(+)-DN-2327或地西泮混合(每种化合物的目标剂量:100和300毫克/千克/天)。在替代期内与基础饮食组相比,S-(+)-DN-2327组和地西泮组的体重和食物消耗量的下降均受到抑制。4. 这些结果表明,S-(+)-DN-2327产生身体依赖性的倾向极小,但与苯二氮䓬受体完全激动剂一样,对巴比妥表现出交叉依赖性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验